Report in English with a Dutch summary (KCE reports 45A)

More documents

Recommendations

Info

184 Screening for Colorectal Cancer: Appendices KCE reports vol.45 Nr. Title Issued by Year Familial Adenomatous Polyposis (FAP) & related 11 Follow-up na poliepectomie - Herziene richtlijn 189. Kwaliteitsinstituut voor de Gezondheidszorg (CBO - NL) 2002 1. Genetic counseling and testing is recommended for all family members with a familial history compatible with criteria for HNPCC, FAP or attenuated FAP. Follow-up frequency should be dictated by the outcome of such testing (recommendation level 3). 2. Such genetic counseling and testing is optional for all family members with a familial CRC history or a sporadic CRC at young age. In these cases colorectal surveillance after 3 y is advisable, however supported by little data (recommendation level 4). 2. Such genetic counseling and testing is optional for all family members with a familial CRC history or a sporadic CRC at young age. In these cases colorectal surveillance after 3 y is advisable, however supported by little data (recommendation level 4).3. There is no need for intensivated surveillance in case of colorectal polyps found at young age in combination with a negative familial history (recommendation level 4). Hereditary Non-Polyposis Colon Cancer (HNPCC) 1. Genetic counseling and testing is recommended for all family members with a familial history compatible with criteria for HNPCC, FAP or attenuated FAP. Follow-up frequency should be dictated by the outcome of such testing (recommendation level 3). 2. Such genetic counseling and testing is optional for all family members with a familial CRC history or a sporadic CRC at young age. In these cases colorectal surveillance after 3 y is advisable, however supported by little data (recommendation level 4).3. There is no need for intensivated surveillance in case of colorectal polyps found at young age in combination with a negative familial history (recommendation level 4). Personal history of CRC resection Not included Personal history of colonpolyps 1. CRC risk augments with number of adenomata (level 3). 2. Many adenomata found on follow-up colonoscopy were already present at indexcolonoscopy (level 3). 3. If 2 adenomata found at indexcolonoscopy first FU-colonoscopy at 6 y; if 3 polys, after 3 y (level 3). 4. Patients with cumulative 1 adenoma at 65 y no need for further FUcolonoscopy (level 3). 5. In case of 2 cumulative adenomata at 65 y: continue till 75 y. For 3: lifetime FU colonoscopy warranted (level 4). 6. A completely resected adenoma does not recur (level 4). 7. All resected polyps need histological examination before setting up a surveillance strategy (level 4). 8. DCBE for FU after polypectomy is indicated if endoscopist doubts complete removal of all polyps (level 4). 9. Patients with high risk family history of CRC: more frequent FU warranted (level 4). Inflammatory bowel disease (IBD) Miscellaneous Not included Not included
KCE reports vol.45 Screening for Colorectal Cancer: Appendices 185 Nr. Title Issued by Year Familial Adenomatous Polyposis (FAP) & related 12 Preventive health care, 2001 update: colorectal cancer screening 28. Canadian Task Force on Preventive Health Care (CTFPHC) 2001 1. genetic counseling should be performed prior to genetic testing 2. FS beginning at puberty 3. Individuals from families where the gene mutation has been identified but are negative themselves, require screening similar to the average risk population 4. For at risk individuals where the mutation has not been identified in the family or where genetic testing is not available, screening with annual or biennial FS should be undertaken beginning at puberty Hereditary Non-Polyposis Colon Cancer (HNPCC) 1. Based on Level III evidence, the Task Force recommends screening with colonoscopy in individuals from HNPCC kindreds 2. The ages when screening should begin and the frequency at which colonoscopy should be performed are unclear. Personal history of CRC resection Personal history of colonpolyps Inflammatory bowel disease (IBD) Miscellaneous Not included Not included Not included Not included
Page 1 and 2:
Health Technology Assessment Colore
Page 3 and 4:
Health Technology Assessment Colore
Page 5 and 6:
KCE reports vol.45A Colorectale Kan
Page 7 and 8:
Page 9:
Page 12 and 13:
2 Screening for Colorectal Cancer K
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
10 Screening for Colorectal Cancer
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145: 134 Screening for Colorectal Cancer
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 259 and 260:
This page is left intentionally bla
Page 261:
KCE reports 1. Effectiviteit en kos
show all

Report in English with a Dutch summary (KCE reports 45A)

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?